This Top Canadian Cannabis Stock Remains a Buy Today

Here’s why Hexo Corp. (TSX:HEXO)(NYSE:HEXO) is among the best domestic cannabis players in Canada right now.

| More on:
Cannabis stocks have fallen.
You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more

The cannabis industry has seen some astonishing ups and downs in recent years. After several stocks seeing valuations rise in 2018, downturns in the following two years saw investors steer clear of this sector in general.

Today, this sector is back in high gear, as speculators have taken these stocks on a nice ride. Indeed, it appears that there has never been a better time to jump into cannabis stocks, for those willing to speculate on these growth plays. Amid this new optimism, Hexo (TSX:HEXO)(NYSE:HEXO) has been a three-bagger over the past 12 months.

Here’s why this stock remains one of my top picks in the cannabis sector today.

One in five Canadians consume cannabis

A new study published in Health Report indicates the popularity of cannabis in Canada. It states that at least one in five Canadians consumed cannabis in the last three months, which is a striking 14% rise in reported use after legalization in October 2018. Daily or almost daily use also reportedly rose from 2019’s 6.1% to 7.9% in late 2020.

The pandemic directly or indirectly caused this increase in cannabis consumption, as almost 34% of Canadians reported that consumption increased compared to the pre-pandemic period. Indeed, 68% of cannabis users said they obtained at least some of the consumed cannabis legally in 2020.

Since legalization, countrywide access to legal stores increased eightfold, which might be one reason behind this dramatic rise. Additionally, I believe this trend is sustainable. As governments seek additional revenue to offset budget deficits, cannabis is one lever that can be pulled for tax revenue.

This rise in consumption presents a bullish case for cannabis growers in itself. A boost in sales is enticing for investors who will be betting on the chance at capital appreciation.

Hexo’s strong domestic presence is a key tailwind

Investors looking to take advantage of this demand surge in Canada should look to the country’s strongest players. And in that regard, Hexo is among the best domestic cannabis plays in Canada.

Hexo has been making some interesting moves to grow its market share domestically. The company’s planned acquisition of Zenabis Global for $235 million will cement its position as one of the top three players in the recreational market. Furthermore, its partnership with Molson Coors provides an excellent opportunity for exposure to the U.S. cannabis market.

Hexo is an excellent domestic play that is heavily focused on dominating the domestic cannabis market. It has secured a massive market share in Quebec, which is one of the largest cannabis markets in the country. Quebec’s provincial government also heavily supports its local businesses via lucrative contracts to support long-term operations.

For those seeking a high-quality Canadian cannabis player, I’d recommend checking out Hexo today.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Chris MacDonald has no position in any of the stocks mentioned. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

IMAGE OF A NOTEBOOK WITH TFSA WRITTEN ON IT
Cannabis Stocks

TFSA Investors: 2 U.S. Stocks I’m Never Selling

Canadians looking to diversify their portfolios and gain exposure to U.S. stocks can purchase shares of high-growth companies such as…

Read more »

A cannabis plant grows.
Cannabis Stocks

Aurora Cannabis (TSX:ACB) Keeps Burning Cash as Revenue Falls

Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) is still losing money. Its revenue is declining, too.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

Why Canopy Growth Stock Climbed as Much as 20% on Monday

A glimmer of hope from the U.S. Congress may lead to renewed interest in marijuana investing.

Read more »

TSX Today
Cannabis Stocks

TSX Today: What to Watch for in Stocks on Friday, July 15

A continued selloff in metals prices is likely to pressure the commodity-heavy TSX Composite benchmark at the open today.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

With the Cannabis Industry Trading Ultra-Cheap, Organigram Stock Looks Like a Screaming Buy!

After selling off for years, Organigram stock now offers tonnes of value and is easily one of the best cannabis…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Canopy Growth Stock: The Only Cannabis Stock to Consider Long Term

The cannabis stock industry remains an incredibly high risk one, but Canopy Growth (TSX:WEED)(NYSE:CGC) stock provides the best opportunity for…

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Should You Stay Away From HEXO Stock?

HEXO (TSX:HEXO)(NASDAQ:HEXO) stock is on a downward spiral, and there is little hope it is going to recover soon.

Read more »

edit Cannabis leaves of a plant on a dark background
Cannabis Stocks

Why Did Aurora Cannabis (TSX:ACB) Stock Plunge 75% in 2022?

A prominent cannabis stock has plunged by 75% in 2022, as the company’s losses continue to mount in the face…

Read more »